Pooled platelet concentrates provide a small benefit over single-donor platelets for patients with platelet refractoriness of any etiology
Background At our institution, patients with platelet refractoriness (of any etiology) are sometimes switched from apheresis platelets to pooled platelets before human leukocyte antigen (HLA)-matched units become available. Study design and methods Seven patients were analyzed. Platelet counts were...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-05-01
|
Series: | Journal of International Medical Research |
Online Access: | https://doi.org/10.1177/03000605211016748 |